Altruista Health CEO Ashish Kachru says he's not bothered by the hype or the disappointment that has been associated with the development of artificial intelligence in health care. "Incremental progress for health care AI may not astonish, but it is nonetheless very promising," Kachru writes.

Biopharmaceutical companies stand to benefit from digital transformation, particularly by using artificial intelligence to analyze and apply manufacturing and supply chain data, write experts from Deloitte. "The ability to adjust processes and track medications in real time will allow biopharma companies to manage their supply, quality, safety, security and costs, resulting in more intelligent manufacturing and supply chain decision-making," they write.

NarxCare analytics platform, now integrated into Rite Aid's pharmacy clinical workflow, accesses state prescription drug monitoring programs to give pharmacists the ability to identify those at risk for medication misuse or abuse. The platform uses machine learning and AI to quickly analyze PDMP data in real-time.

A group of financial industry experts discussed the opportunities and challenges of artificial intelligence and other emerging technologies such as regtech at the SIFMA Fintech Conference in New York last week. A key agreement was that benefits will undoubtedly be delivered but challenges remain, particularly in coordinating with regulators and translating theory into practice in real-time transactions and operations.